Sexual Harassment Prevention Training - Designated Coordinator - University System of Maryland
Sponsor: Delegate HettlemanCommittee: AppropriationsSubject: State Government - General AssemblyStatus: Enacted under Article II, Section 17(c) of the Maryland Constitution - Chapter 168 (as of Nov 6, 2020)
What this bill does
Official synopsis
Applying certain sexual harassment prevention training requirements to all units in the Executive, Judicial, and Legislative branches of State government and to each constituent institution of the University System of Maryland; and repealing the requirement that a certain representative designated by a unit of the University System of Maryland to coordinate certain sexual harassment prevention training be the unit's Title IX Coordinator.
AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.
Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.
Testimony (6)
MGA witness listFAV 5FavorableFWA 1Favorable with amendments
| Position | Witness | Organization | Testimony |
|---|---|---|---|
| FAV | Dove, Spencer | MCCR | Written (PDF) |
| FAV | Hughes, Glendora | State of Maryland Commission on Civil Rights | Position only |
| FAV | Hogan, Patricklobbyist | University System of Maryland | Oral + Written (PDF) |
| FAV | Delegate Hettleman, Delegate Hettlemanlegislator | Individual | Position only |
| FAV | Hettleman, Shelly | Individual | Oral + Written (PDF) |
| FWA | hogan, patricklobbyist | usm | Oral + Written (PDF) |
Organizations on record
Registered lobbyists who testified
FAVHogan, PatrickUniversity System of MarylandRegistered for: ALS Association, The; Adobe Inc.; Amgen, Inc.; Annie E. Casey Foundation, Inc., The; AstraZeneca Pharmaceuticals, LP; Capital One…
FWAhogan, patrickusmRegistered for: ALS Association, The; Adobe Inc.; Amgen, Inc.; Annie E. Casey Foundation, Inc., The; AstraZeneca Pharmaceuticals, LP; Capital One…